Pacific Biosciences Of California Revenue 2012-2026 | PACB
Pacific Biosciences Of California revenue from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Pacific Biosciences Of California Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $160 |
| 2024 | $154 |
| 2023 | $201 |
| 2022 | $128 |
| 2021 | $131 |
| 2020 | $79 |
| 2019 | $91 |
| 2018 | $79 |
| 2017 | $93 |
| 2016 | $91 |
| 2015 | $93 |
| 2014 | $61 |
| 2013 | $28 |
| 2012 | $26 |
| 2011 | $34 |
|
Pacific Biosciences Of California Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-03-31 | $37 |
| 2025-12-31 | $45 |
| 2025-09-30 | $38 |
| 2025-06-30 | $40 |
| 2025-03-31 | $37 |
| 2024-12-31 | $39 |
| 2024-09-30 | $40 |
| 2024-06-30 | $36 |
| 2024-03-31 | $39 |
| 2023-12-31 | $58 |
| 2023-09-30 | $56 |
| 2023-06-30 | $48 |
| 2023-03-31 | $39 |
| 2022-12-31 | $27 |
| 2022-09-30 | $32 |
| 2022-06-30 | $35 |
| 2022-03-31 | $33 |
| 2021-12-31 | $36 |
| 2021-09-30 | $35 |
| 2021-06-30 | $31 |
| 2021-03-31 | $29 |
| 2020-12-31 | $27 |
| 2020-09-30 | $19 |
| 2020-06-30 | $17 |
| 2020-03-31 | $16 |
| 2019-12-31 | $28 |
| 2019-09-30 | $22 |
| 2019-06-30 | $25 |
| 2019-03-31 | $16 |
| 2018-12-31 | $20 |
| 2018-09-30 | $18 |
| 2018-06-30 | $22 |
| 2018-03-31 | $19 |
| 2017-12-31 | $25 |
| 2017-09-30 | $24 |
| 2017-06-30 | $20 |
| 2017-03-31 | $25 |
| 2016-12-31 | $26 |
| 2016-09-30 | $25 |
| 2016-06-30 | $21 |
| 2016-03-31 | $19 |
| 2015-12-31 | $36 |
| 2015-09-30 | $14 |
| 2015-06-30 | $25 |
| 2015-03-31 | $18 |
| 2014-12-31 | $17 |
| 2014-09-30 | $21 |
| 2014-06-30 | $11 |
| 2014-03-31 | $12 |
| 2013-12-31 | $9 |
| 2013-09-30 | $7 |
| 2013-06-30 | $6 |
| 2013-03-31 | $6 |
| 2012-12-31 | $6 |
| 2012-09-30 | $3 |
| 2012-06-30 | $7 |
| 2012-03-31 | $10 |
| 2011-12-31 | $12 |
| 2011-09-30 | $11 |
| 2011-06-30 | $11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.410B | $0.160B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $172.436B | 20.03 |
| Intuitive Surgical (ISRG) | United States | $142.710B | 51.59 |
| Edwards Lifesciences (EW) | United States | $49.450B | 31.81 |
| IDEXX Laboratories (IDXX) | United States | $43.049B | 40.19 |
| Waters (WAT) | United States | $35.175B | 26.38 |
| Alcon (ALC) | Switzerland | $32.239B | 20.50 |
| IQVIA Holdings (IQV) | United States | $28.007B | 15.06 |
| DexCom (DXCM) | United States | $26.652B | 29.64 |
| Mettler-Toledo (MTD) | United States | $23.523B | 26.75 |
| STERIS (STE) | Ireland | $19.531B | 19.70 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.276B | 0.00 |
| Coloplast (CLPBY) | Denmark | $12.868B | 17.30 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.635B | 9.28 |
| Penumbra (PEN) | United States | $12.437B | 82.56 |
| Globus Medical (GMED) | United States | $10.750B | 17.84 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $7.705B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Teleflex (TFX) | United States | $5.386B | 11.35 |
| Sysmex ADR (SSMXY) | Japan | $5.369B | 22.45 |
| LivaNova (LIVN) | United Kingdom | $4.324B | 22.49 |
| Veracyte (VCYT) | United States | $4.244B | 36.43 |
| Integer Holdings (ITGR) | United States | $3.059B | 14.30 |
| TransMedics (TMDX) | United States | $2.610B | 30.82 |
| AxoGen (AXGN) | United States | $2.390B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.821B | 19.76 |
| UFP Technologies (UFPT) | United States | $1.805B | 23.78 |
| Pulse Biosciences (PLSE) | United States | $1.779B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.460B | 12.38 |
| Integra LifeSciences Holdings (IART) | United States | $1.369B | 7.46 |
| Alphatec Holdings (ATEC) | United States | $1.315B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.199B | 0.00 |
| IRadimed (IRMD) | United States | $1.172B | 50.10 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.167B | 27.67 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.983B | 0.00 |
| Artivion (AORT) | United States | $0.977B | 30.97 |
| Anteris Technologies Global (AVR) | Australia | $0.934B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.906B | 0.00 |
| SiBone (SIBN) | United States | $0.702B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.610B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 29.80 |
| NeuroPace (NPCE) | United States | $0.524B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.65 |
| AngioDynamics (ANGO) | United States | $0.512B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.512B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.466B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.397B | 1151.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.362B | 0.00 |
| 908 Devices (MASS) | United States | $0.327B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.285B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.260B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.209B | 0.00 |
| RxSight (RXST) | United States | $0.205B | 0.00 |
| FocalTherics (FOCL) | France | $0.184B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Hyperfine (HYPR) | United States | $0.148B | 0.00 |
| CVRx (CVRX) | United States | $0.129B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.124B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.113B | 0.00 |
| Neuronetics (STIM) | United States | $0.084B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.073B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Precision Optics (POCI) | United States | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Envoy Medical (COCH) | United States | $0.051B | 0.00 |
| DarioHealth (DRIO) | United States | $0.046B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.046B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.045B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Accuray (ARAY) | United States | $0.037B | 0.00 |
| InspireMD (NSPR) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| NexGel (NXGL) | United States | $0.006B | 0.00 |
| PAVmed (PAVM) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |